LogicBio Therapeutics, Inc. Banner Image

LogicBio Therapeutics, Inc.

  • Ticker LOGC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
LogicBio Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Lexington, Massachusetts
LogicBio Therapeutics is dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms. LogicBio’s proprietary genome editing technology platform, GeneRide, enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. LogicBio is also developing aMore Next Generation Capsid platform for use in gene editing and gene therapies. LogicBio is developing these highly potent vectors for internal development candidates and potentially for business development collaborations. LogicBio is headquartered in Lexington, Mass.
4.7 / 5.0 (122)

LogicBio Therapeutics, Inc. reports have an aggregate usefulness score of 4.7 based on 122 reviews.

LogicBio Therapeutics, Inc.

Most Recent Annual Report

LogicBio Therapeutics, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports

LogicBio Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!